Variability in interpreting and reporting copy number changes detected by array-based technology in clinical laboratories

Purpose: The purpose of this study was to assess the variability in interpretation and reporting of copy number changes that are detected by array-based technology in the clinical laboratory.Methods: Thirteen different copy number changes, detected by array comparative genomic hybridization, that have not been associated with an abnormal phenotype in the literature were evaluated by directors from 11 different clinical laboratories to determine how they would interpret and report the findings.Results: For none of the thirteen copy number changes was there complete agreement in the interpretation of the clinical significance of the deletion or duplication. For some cases, the interpretations ranged from normal to abnormal.Conclusion: There is a need for more specific guidelines for interpreting and reporting copy number changes detected by array-based technology to clearly and more consistently communicate the clinical significance of these findings to ordering providers.

[1]  Xiaowu Gai,et al.  High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications. , 2009, Genome research.

[2]  J. Canick,et al.  Technical standards and guidelines: Prenatal screening for Down syndrome that includes first-trimester biochemistry and/or ultrasound measurements , 2009, Genetics in Medicine.

[3]  Erik Sistermans,et al.  Genomic microarrays in mental retardation: A practical workflow for diagnostic applications , 2009, Human mutation.

[4]  Richard M Myers,et al.  Population analysis of large copy number variants and hotspots of human genetic disease. , 2009, American journal of human genetics.

[5]  P. Stankiewicz,et al.  Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities , 2008, Nature Genetics.

[6]  A. Spurdle,et al.  Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results , 2008, Human mutation.

[7]  L. Shaffer,et al.  Identification of a previously unrecognized microdeletion syndrome of 16q11.2q12.2 , 2008, Clinical genetics.

[8]  S. Scherer,et al.  Contemplating effects of genomic structural variation , 2008, Genetics in Medicine.

[9]  W. Grody,et al.  ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007 , 2008, Genetics in Medicine.

[10]  H. Mefford,et al.  Recurrent reciprocal deletions and duplications of 16p13.11: the deletion is a risk factor for MR/MCA while the duplication may be a rare benign variant , 2008, Journal of Medical Genetics.

[11]  P. Mundy,et al.  Detection of pathogenic gene copy number variations in patients with mental retardation by genomewide oligonucleotide array comparative genomic hybridization , 2007, Human mutation.

[12]  H. Fiegler,et al.  Guidelines for molecular karyotyping in constitutional genetic diagnosis , 2007, European Journal of Human Genetics.

[13]  Charles Lee,et al.  Copy number variations and clinical cytogenetic diagnosis of constitutional disorders , 2007, Nature Genetics.

[14]  Fikret Erdogan,et al.  Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation , 2007, Human mutation.

[15]  S. Patil,et al.  Cytogenetic heteromorphisms: survey results and reporting practices of giemsa-band regions that we have pondered for years. , 2006, Archives of pathology & laboratory medicine.

[16]  L. Feuk,et al.  Detection of large-scale variation in the human genome , 2004, Nature Genetics.

[17]  J. Stockman.  Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes , 2010 .

[18]  L. Shaffer,et al.  ISCN 2009 - An International System for Human Cytogenetic Nomenclature , 2009 .

[19]  Iscn.  International System for Human Cytogenetic Nomenclature , 1978 .